LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
4.290
+0.790 (22.57%)
At close: Nov 9, 2026, 4:00 PM EST
4.280
-0.010 (-0.23%)
Pre-market: Nov 10, 2026, 5:46 AM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $134.79 million as of November 9, 2026. It is the 23,008th most valuable company in the world and the 3,858th biggest in the United States. Its market cap has decreased by 81.25% in one year.
Market Cap
134.79M
Enterprise Value
-62.05M
1-Year Change
-81.25%
Global Rank
Country Rank
#3,858 United States
Category
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $134.79M, a decrease of -67.41%. That is a compound annual growth rate of -34.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 134.79M | -73.08% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 116.04M |
| Minerva Neurosciences | 115.55M |
| Voyager Therapeutics | 114.92M |
| Foghorn Therapeutics | 111.05M |
| Anixa Biosciences | 110.38M |
| Milestone Pharmaceuticals | 107.49M |
| Anavex Life Sciences | 106.60M |
| Outlook Therapeutics | 106.24M |